• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对泼尼松、柳氮磺胺吡啶和局部用半琥珀酸氢化可的松作为溃疡性结肠炎门诊治疗药物的评估。

An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis.

作者信息

LENNARD-JONES J E, LONGMORE A J, NEWELL A C, WILSON C W, JONES F A

出版信息

Gut. 1960 Sep;1(3):217-22. doi: 10.1136/gut.1.3.217.

DOI:10.1136/gut.1.3.217
PMID:13760840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1413184/
Abstract

Two consecutive trials of out-patient treatment for mild cases of active ulcerative colitis are described. In the first trial oral prednisone gave significantly better results than a placebo. In the second trial "salazopyrin" gave final results approaching those of prednisone, although over a longer time and with a higher incidence of unpleasant side-effects, but topical hydrocortisone gave disappointing results, probably because the technique of administration was not suitable for ordinary out-patient use.

摘要

本文描述了针对轻度活动性溃疡性结肠炎门诊治疗的两项连续试验。在第一项试验中,口服泼尼松的效果明显优于安慰剂。在第二项试验中,“柳氮磺胺吡啶”的最终效果接近泼尼松,尽管起效时间更长且不良反应发生率更高,但局部使用氢化可的松的效果令人失望,可能是因为给药技术不适合普通门诊使用。

相似文献

1
An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis.对泼尼松、柳氮磺胺吡啶和局部用半琥珀酸氢化可的松作为溃疡性结肠炎门诊治疗药物的评估。
Gut. 1960 Sep;1(3):217-22. doi: 10.1136/gut.1.3.217.
2
A comparative trial of salazopyrin, prednisone and hydrocortisone retention enemata in the out-patient treatment of left-sided colitis. Preliminary report.柳氮磺胺吡啶、泼尼松和氢化可的松保留灌肠剂门诊治疗左侧结肠炎的比较试验。初步报告。
Proc R Soc Med. 1960 Aug;53(8):647-50. doi: 10.1177/003591576005300817.
3
[A medical treatment of ulcerative colitis: salazopyrin].[溃疡性结肠炎的一种医学治疗方法:柳氮磺胺吡啶]
Minerva Gastroenterol. 1961 Jan-Mar;7:21-7.
4
Sulphasalazine and salicylazosulphadimidine in ulcerative colitis.柳氮磺胺吡啶和水杨酸偶氮磺胺嘧啶治疗溃疡性结肠炎
Lancet. 1962 May 26;1(7239):1094-6. doi: 10.1016/s0140-6736(62)92080-9.
5
A critical analysis of the use of salicylazosulfapyridine in chronic ulcerative colitis.柳氮磺胺吡啶在慢性溃疡性结肠炎中的应用批判性分析。
Ann Intern Med. 1959 Nov;51:879-89. doi: 10.7326/0003-4819-51-5-879.
6
Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone.溃疡性结肠炎的门诊治疗。三种剂量口服泼尼松的比较。
Br Med J. 1962 Aug 18;2(5302):441-3. doi: 10.1136/bmj.2.5302.441.
7
Experience with short and long term courses of local adrenal steroid therapy for ulcerative colitis. Report of 98 cases.溃疡性结肠炎局部肾上腺皮质类固醇短期和长期治疗经验。98例报告。
Gastroenterology. 1962 Jun;42:669-77.
8
[Ulcerative colitis and its therapy, especially with azulfidine].[溃疡性结肠炎及其治疗,尤其是柳氮磺胺吡啶治疗]
Munch Med Wochenschr. 1961 Aug 18;103:1576-8.
9
Medical management of ulcerative colitis.溃疡性结肠炎的医学管理
Br Med J. 1961 Jan 21;1(5220):147-51. doi: 10.1136/bmj.1.5220.147.
10
Studies of the bone marrow in immunological granulocytopenia; following administration of salicylazosulfapyridine.免疫性粒细胞减少症患者骨髓的研究;在给予柳氮磺胺吡啶之后。
AMA Arch Intern Med. 1958 Feb;101(2):244-51. doi: 10.1001/archinte.1958.00260140076012.

引用本文的文献

1
Factors Associated with Response to Systemic Corticosteroids in Active Ulcerative Colitis: Results from a Prospective, Multicenter Trial.活动性溃疡性结肠炎中与全身用皮质类固醇反应相关的因素:一项前瞻性多中心试验的结果
J Clin Med. 2023 Jul 24;12(14):4853. doi: 10.3390/jcm12144853.
2
Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology.溃疡性结肠炎管理指南。波兰胃肠病学会及波兰国家胃肠病学顾问的建议。
Prz Gastroenterol. 2023;18(1):1-42. doi: 10.5114/pg.2023.125882. Epub 2023 Mar 15.
3
Analysis of the initial dose and reduction rate of corticosteroid for ulcerative colitis in clinical practice.临床实践中溃疡性结肠炎糖皮质激素初始剂量及减量率分析
JGH Open. 2022 Aug 20;6(9):612-620. doi: 10.1002/jgh3.12796. eCollection 2022 Sep.
4
Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis.粪便微生物群移植与糖皮质激素治疗轻中度溃疡性结肠炎诱导缓解的比较。
J Transl Med. 2022 Aug 12;20(1):354. doi: 10.1186/s12967-022-03569-3.
5
Inflammatory bowel disease biomarkers.炎症性肠病生物标志物。
Med Res Rev. 2022 Sep;42(5):1856-1887. doi: 10.1002/med.21893. Epub 2022 May 23.
6
Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice.炎症性肠病中的糖皮质激素治疗:机制与临床实践。
Front Immunol. 2021 Jun 3;12:691480. doi: 10.3389/fimmu.2021.691480. eCollection 2021.
7
Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis.评估粪便微生物群移植和益生菌 VSL#3 治疗活动期溃疡性结肠炎的疗效和安全性:系统评价和荟萃分析。
PLoS One. 2020 Mar 17;15(3):e0228846. doi: 10.1371/journal.pone.0228846. eCollection 2020.
8
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.英国胃肠病学会成人炎症性肠病管理共识指南。
Gut. 2019 Dec;68(Suppl 3):s1-s106. doi: 10.1136/gutjnl-2019-318484. Epub 2019 Sep 27.
9
Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology.炎症性肠病的糖皮质激素治疗:从临床实践到分子生物学。
World J Gastroenterol. 2017 Sep 28;23(36):6628-6638. doi: 10.3748/wjg.v23.i36.6628.
10
Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?炎症性肠病治疗的临床应答和缓解时间:临床医生应该期待什么,应该告诉患者什么?
World J Gastroenterol. 2017 Sep 21;23(35):6385-6402. doi: 10.3748/wjg.v23.i35.6385.

本文引用的文献

1
Observations on the Management of Idiopathic Proctitis [Abridged].特发性直肠炎的治疗观察[节略版]
Proc R Soc Med. 1958 Jun;51(6):431. doi: 10.1177/003591575805100609.
2
A critical analysis of the use of salicylazosulfapyridine in chronic ulcerative colitis.柳氮磺胺吡啶在慢性溃疡性结肠炎中的应用批判性分析。
Ann Intern Med. 1959 Nov;51:879-89. doi: 10.7326/0003-4819-51-5-879.
3
Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium; a controlled trial employing restricted sequential analysis.用半琥珀酸氢化可的松钠局部治疗溃疡性结肠炎;一项采用受限序贯分析的对照试验。
Br Med J. 1958 Nov 1;2(5104):1077-82. doi: 10.1136/bmj.2.5104.1077.
4
Treatment of ulcerative colitis with local hydrocortisone.局部氢化可的松治疗溃疡性结肠炎
Proc R Soc Med. 1958 Jun;51(6):429-31. doi: 10.1177/003591575805100608.
5
Rectal hydrocortisone.直肠用氢化可的松
Br Med J. 1957 Aug 3;2(5039):272-4. doi: 10.1136/bmj.2.5039.272.
6
The treatment of ulcerative colitis.溃疡性结肠炎的治疗
Gastroenterologia. 1956;86(5):683-8. doi: 10.1159/000200641.